Cancer clinical trials in the region Occitanie
174 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT03915678
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Immunotherapy
1
2
3 or more
Systemic Treatment-Naive
6 main criterias to confirm
IUCT Oncopôle (Toulouse)
Institut Bergonié
Phase 2
Liver and bile duct cancer
#NCT03727633
Hepatocellular carcinoma
Localized
Systemic Treatment-Naive
None
Unhealthy
A
B
A
B
C
8 main criterias to confirm
Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier)
CHU de Montpellier
Phase 2
Liver and bile duct cancer
#NCT03475953
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
4 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2
Breast cancer
#NCT03475953
HER2 Negative
HR Negative
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
Immunotherapy
Bispecific T-cell engager antibodies
6 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2
Lung cancer
#NCT03475953
NSCLC (Non-Small Cell Lung Cancer)
Mesothelium
Non-squamous NSCLC
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Targeted therapy
Antibody Drug Conjugates (ADC)
1
2
3 or more
ALK
EGFR
ROS-1
Systemic Treatment-Naive
8 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2
Kidney cancer
#NCT03475953
Other
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2
Kidney cancer
#NCT03475953
Clear cell carcinoma
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2
Colon cancer
Rectal cancer
#NCT03475953
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Targeted therapy
Antibody Drug Conjugates (ADC)
1
2
3 or more
Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2
Stomach and esophageal cancer
#NCT03475953
Stomach
Esophagus
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut Bergonié
Phase 2
Breast cancer
#NCT03424005
HER2 Low
HER2 Positive
HR Positive
Locally Advanced
Metastatic
PIK3CA
1
2
3 or more
Systemic Treatment-Naive
7 main criterias to confirm
IUCT Oncopôle (Toulouse)
Hoffmann-La Roche